PPH icon

VanEck Pharmaceutical ETF
PPH

Overview Fund Activity

51 hedge funds and large institutions have $188M invested in VanEck Pharmaceutical ETF in 2021 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 12 increasing their positions, 9 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
51
Holders Change
+3
Holders Change %
+6.25%
% of All Funds
0.9%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
12
Reduced
9
Closed
5
Calls
$1.12M
Puts
$41.8M
Net Calls
-$40.6M
Net Calls Change
-$18.1M

Top Buyers

1
Goldman Sachs
Goldman Sachs
New York
+$84.7M
2
Bank of America
Bank of America
North Carolina
+$34.2M
3
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
+$13.8M
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$2.86M
5
Citadel Advisors
Citadel Advisors
Florida
+$2.7M

Top Sellers

1
MTWSIF
Mivtachim The Workers Social Insurance Fund
Israel
-$22.9M
2
CCP
Clough Capital Partners
Massachusetts
-$22M
3
BCI
Brinker Capital Investments
Pennsylvania
-$2.76M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$825K
5
OPS
Orion Portfolio Solutions
Nebraska
-$288K
Name Holding Trade Value Shares
Change 		Shares
Change %
MIH
51
Meitav Investment House
Israel
$338 +$338 +4,895 New
MTWSIF
52
Mivtachim The Workers Social Insurance Fund
Israel
– -$22.9M -344,000 Closed
CCP
53
Clough Capital Partners
Massachusetts
– -$22M -330,400 Closed
ASN
54
Advisory Services Network
Georgia
– -$85K -1,275 Closed
MIM
55
Macroview Investment Management
Maryland
– -$20K -300 Closed
FWM
56
Focused Wealth Management
New York
– -$15K -222 Closed
1 2
3